The Chemours Company (CC) vs Stepan Company (SCL)
The Chemours Company and Stepan Company are both Specialty Chemicals companies. The Chemours Company is the larger, with a market value of $2.1B against $1.5B — 1.5× the size. Stepan Company grew revenue faster over the last twelve months: 7.63% against −0.89%. Stepan Company has the higher net margin (−0.11% vs −5.24%) and the higher return on invested capital (0.71% vs −2.22%). Both pay a dividend; The Chemours Company yields more (3.32% vs 1.65%). Across the 21 metrics below, Stepan Company leads on 12 and The Chemours Company on 9.
Valuation
Profitability
| Metric | CC | SCL | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 15.28% | 11.81% | 29.23% |
| Operating margin | (1.93%) | 0.82% | 3.63% |
| Net margin | (5.24%) | (0.11%) | 2.89% |
| Free cash flow margin | 3.76% | 2.60% | 3.78% |
| Return on equity | (318.32%) | (0.22%) | 3.62% |
| Return on assets | (4.15%) | (0.11%) | 0.35% |
| Return on invested capital | (2.22%) | 0.71% | 2.75% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack